Noor Ul Ain Rehman
Tue, February 10, 2026 astatine 5:41 AM CST 2 min read
In a abstracted development, Sanofi (NASDAQ:SNY) announced affirmative results for the LEAP2MONO signifier 3 survey connected February 2, stating that venglustat met the superior and 3 retired of 4 cardinal secondary endpoints successful adults and pediatric patients 12 years and older with neurological manifestations of benignant 3 Gaucher disease, which is simply a uncommon lysosomal retention disorder. Sanofi (NASDAQ:SNY) clarified that Venglustat is an investigational glucosylceramide synthase inhibitor (GCSi) that works by bringing down the abnormal accumulation of sugar-and-fat molecules successful cells and organs.
Sanofi (NASDAQ:SNY) researches, produces, and distributes pharmaceutical products. The company’s operations are divided into the Pharmaceuticals, Consumer Healthcare, and Vaccines segments.
While we admit the imaginable of XXXX arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.
READ NEXT: 30 Stocks That Should Double successful 3 Years and 11 Hidden AI Stocks to Buy Right Now.
Disclosure: None. This nonfiction is primitively published at Insider Monkey.

1 month ago
24




English (CA) ·
English (US) ·
Spanish (MX) ·